CryoPort, Inc. Common Stock

CYRXNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
15.70 USD
↘ 0.46 (2.85%)AT CLOSE (11:59 AM EDT)
15.68
↘ 0.02 (0.10%)
POST MARKET (AS OF 06:53 PM EDT)
Post Market
AS OF 06:53 PM EDT
15.68
↘ 0.02 (0.10%)
🔴Market: CLOSED
Open?$16.10
High?$16.10
Low?$15.52
Prev. Close?$16.16
Volume?710.8K
Avg. Volume?879.2K
VWAP?$15.74
Rel. Volume?0.81x
Bid / Ask
Bid?$13.46 × 100
Ask?$18.07 × 100
Spread?$4.61
Midpoint?$15.77
Valuation & Ratios
Market Cap?791.3M
Shares Out?50.4M
Float?48.2M
Float %?96.1%
P/E Ratio?11.63
P/B Ratio?1.60
EPS?$1.35
Dividend?0.00%
Ex-Dividend?N/A

CryoPort, Inc. Common Stock (CYRX) is currently trading at $15.70. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
738
Market Cap
791.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.cryoportinc.com
Listed
1993-07-16
Address
112 WESTWOOD PLACE, SUITE 350
BRENTWOOD, TN 37027
Phone: (949) 232-1900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
10
Momentum?
62
Short Sent.?
80
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.94Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.94%Low
Short Interest?1.9M
Days to Cover?2.4
Free Float48.2M
Avg Daily Volume802.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.09Strong
Quick Ratio?2.00Strong
Cash Ratio?1.21Strong
Debt/Equity?0.38Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
87/100
P/E?
Peers
100
S&P
92
11.6CHEAP▾
P/B?
Peers
100
S&P
85
1.60CHEAP▾
P/S?
Peers
100
S&P
35
4.33FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-55.3CHEAP▾
EV/Sales?
Peers
100
S&P
49
3.86FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
50
13.8%STRONG▾
ROA?
Peers
50
S&P
70
8.9%STRONG▾
Cash Flow & Enterprise
FCF?$-28938000
Enterprise Value?$706.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist